<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">23323070</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>01</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1516-8484</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>34</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2012</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Revista brasileira de hematologia e hemoterapia</Title>
                <ISOAbbreviation>Rev Bras Hematol Hemoter</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pathophysiology and molecular aspects of diffuse large B-cell lymphoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>447-51</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5581/1516-8484.20120111</ELocationID>
            <Abstract>
                <AbstractText>Diffuse large B-Cell lymphoma is the most common subtype of non-Hodgkin lymphoma in the West. In Brazil, it is the fifth cause of cancer, with more than 55,000 cases and 26,000 deaths per year. At Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - HCFMUSP, diffuse large B-Cell lymphoma represents 49.7% of all non-Hodgkin lymphoma cases. Initially, the classification of non-Hodgkin lymphoma was based on morphology, but advances in immunology and molecular medicine allowed the introduction of a biological classification for these diseases. As for other cancers, non-Hodgkin lymphoma involves patterns of multifactorial pathogenesis with environmental factors, as well as genetic, occupational and dietary factors, contributing to its development. Multiple lesions involving molecular pathways of B-cell proliferation and differentiation may result in the activation of oncogenes such as the BCL2, BCL6, and MYC genes and the inactivation of tumor suppressor genes such as p53 and INK4, as well as other important transcription factors such as OCT-1 and OCT-2. A dramatic improvement in survival was seen after the recent introduction of the anti-CD20 monoclonal antibody. The association of this antibody to the cyclophosphamide, hydroxydaunorubicin, oncovin and prednisolone (CHOP) regimen has increased overall survival of diffuse large B-Cell lymphoma and follicular lymphoma patients by 20%. However, 50% of all diffuse large B-Cell lymphoma patients remain incurable, creating a demand for more research with new advances in treatment. Thus, it is important to know and understand the key factors and molecular pathways involved in the pathogenesis of diffuse large B-Cell lymphoma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gouveia</LastName>
                    <ForeName>Gisele Rodrigues</ForeName>
                    <Initials>GR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo - USP, São Paulo, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siqueira</LastName>
                    <ForeName>Sheila Aparecida Coelho</ForeName>
                    <Initials>SA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Juliana</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Brazil</Country>
            <MedlineTA>Rev Bras Hematol Hemoter</MedlineTA>
            <NlmUniqueID>101220159</NlmUniqueID>
            <ISSNLinking>1516-8484</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Genes, tumor suppressor</Keyword>
            <Keyword MajorTopicYN="N">Lymphoma</Keyword>
            <Keyword MajorTopicYN="N">Lymphoma, B-cell/physiopathology</Keyword>
            <Keyword MajorTopicYN="N">Oncogenes</Keyword>
            <Keyword MajorTopicYN="N">Prognosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>04</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>09</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23323070</ArticleId>
            <ArticleId IdType="doi">10.5581/1516-8484.20120111</ArticleId>
            <ArticleId IdType="pmc">PMC3545433</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Pathol. 2001 Dec;159(6):2031-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11733354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mod Pathol. 2002 Mar;15(3):211-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11904338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Bras Hematol Hemoter. 2011;33(4):317</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23049326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2010 Apr 15;362(15):1417-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20393178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 2007 Jul;51(1):70-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17593082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Sep 1;24(25):4135-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16943530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Clin (Barc). 2006 Jun 3;127(1):17-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16796936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mod Pathol. 2006 Jul;19(7):1010-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16648862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2006 May;7(5):379-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16648042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2006 May;7(5):357-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16648037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Feb 20;24(6):961-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16418494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2006 Feb 9;25(6):888-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16186795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2006 Jan 15;106(2):247-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16342164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Egypt Natl Canc Inst. 2005 Mar;17(1):20-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16353079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2005 Sep 10;23(26):6351-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16155019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1996 Sep 15;88(6):2361-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8822962</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1996 Jul;14(7):2131-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8683246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1988 Apr 1;61(7):1371-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2449945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1990 Apr;14(4):329-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2321697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 1990 Sep;17(3):211-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2173674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leuk Lymphoma. 1994 Mar;13(1-2):81-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8025526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1994 Sep 1;84(5):1359-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8068935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1994 Sep 1;84(5):1361-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8068936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1995 Feb 1;85(3):857-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7833492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1995 Apr 1;85(7):1972-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7703501</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicina (B Aires). 1995;55(2):159-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7565055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1996 Jan 1;87(1):412-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8547670</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>